Search Results - "Strippoli, G. F."

Refine Results
  1. 1

    Antihypertensive agents for preventing diabetic kidney disease by Strippoli, G F M, Craig, M, Craig, J C

    Published in Cochrane database of systematic reviews (19-10-2005)
    “…Twenty to sixty percent of diabetic patients are affected by hypertension and antihypertensive agents are used to treat this condition. These agents are also…”
    Get more information
    Journal Article
  2. 2

    Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease by Strippoli, G F M, Navaneethan, S D, Craig, J C

    Published in Cochrane database of systematic reviews (18-10-2006)
    “…Anaemia affects 60% to 80% of patients with chronic kidney disease (CKD) reduces quality of life and is a risk factor for early death. Treatment options are…”
    Get more information
    Journal Article
  3. 3

    Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients by Strippoli, G F, Hodson, E M, Jones, C J, Craig, J C

    Published in Cochrane database of systematic reviews (25-01-2006)
    “…Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid organ transplant recipients. Pre-emptive treatment with antiviral agents of…”
    Get more information
    Journal Article
  4. 4

    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients by Hodson, E M, Craig, J C, Strippoli, G F M, Webster, A C

    Published in Cochrane database of systematic reviews (01-01-2008)
    “…The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients has resulted in the frequent use of prophylaxis with the aim of preventing the…”
    Get more information
    Journal Article
  5. 5

    Interventions for preventing bone disease in kidney transplant recipients by Palmer, S C, McGregor, D O, Strippoli, G F

    Published in Cochrane database of systematic reviews (18-07-2007)
    “…Patients with chronic kidney disease have significant abnormalities of bone remodeling and mineral homeostasis and are at increased risk of fracture. The…”
    Get more information
    Journal Article
  6. 6

    Treatment for peritoneal dialysis-associated peritonitis by Wiggins, K J, Craig, J C, Johnson, D W, Strippoli, G F

    Published in Cochrane database of systematic reviews (01-01-2008)
    “…Peritonitis is a common complication of peritoneal dialysis (PD) and is associated with significant morbidity. Adequate treatment is essential to reduce…”
    Get more information
    Journal Article
  7. 7

    Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease by Strippoli, G F M, Bonifati, C, Craig, M, Navaneethan, S D, Craig, J C

    Published in Cochrane database of systematic reviews (18-10-2006)
    “…Angiotensin converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (AIIRA) are considered to be equally effective for patients with…”
    Get more information
    Journal Article
  8. 8

    Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients by Strippoli, G F M, Tong, A, Palmer, S C, Elder, G, Craig, J C

    Published in Cochrane database of systematic reviews (18-10-2006)
    “…Calcimimetic agents have recently been evaluated in the treatment of secondary hyperparathyroidism (SHPT) as add-on therapy to calcitriol and vitamin D…”
    Get more information
    Journal Article
  9. 9

    High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial by Vernooij, Robin W.M., Hockham, C., Barth, C., Canaud, B., Cromm, K., Davenport, A., Hegbrant, J., Rose, M., Strippoli, G.F.M., Török, M., Woodward, M., Bots, M.L., Blankestijn, P.J.

    Published in Kidney international reports (01-11-2023)
    “…High convection volumes in hemodiafiltration (HDF) result in improved survival; however, it remains unclear whether it is achievable in all patients. CONVINCE,…”
    Get full text
    Journal Article
  10. 10

    Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients by Hodson, E M, Jones, C A, Strippoli, G F M, Webster, A C, Craig, J C

    Published in Cochrane database of systematic reviews (18-04-2007)
    “…Cytomegalovirus (CMV) is the most common virus causing disease and death in solid organ transplant recipients during the first six months post-transplant…”
    Get more information
    Journal Article
  11. 11

    Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease by Rabindranath, K S, Strippoli, G F, Daly, C, Roderick, P J, Wallace, S, MacLeod, A M

    Published in Cochrane database of systematic reviews (01-01-2006)
    “…Renal replacement therapy (RRT) for end-stage kidney disease (ESKD) can be achieved by several interventions including haemodialysis (HD), peritoneal dialysis…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients by Strippoli, G F M, Tong, A, Johnson, D, Schena, F P, Craig, J C

    Published in Cochrane database of systematic reviews (18-10-2004)
    “…As many as 15-50% of end-stage kidney disease patients are on peritoneal dialysis (PD), but peritonitis limits its more widespread use. Several PD…”
    Get more information
    Journal Article
  14. 14

    Interventions for minimal change disease in adults with nephrotic syndrome by Palmer, S C, Nand, K, Strippoli, G F

    Published in Cochrane database of systematic reviews (23-01-2008)
    “…Steroids have been used widely since the early 1970s for the treatment of adult-onset minimal change disease. The response rates to immunosuppressive agents in…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients by Strippoli, G F M, Tong, A, Johnson, D, Schena, F P, Craig, J C

    Published in Cochrane database of systematic reviews (18-10-2004)
    “…Peritoneal dialysis (PD) is used as substitutive treatment of renal function in a large proportion (15-50%) of the end-stage kidney disease (ESRD) population…”
    Get more information
    Journal Article
  17. 17

    Treatment for lupus nephritis by Flanc, R S, Roberts, M A, Strippoli, G F M, Chadban, S J, Kerr, P G, Atkins, R C

    “…Lupus nephritis is the renal manifestation of systemic lupus erythematosus (SLE) - a disease mainly affecting young women with substantial morbidity and…”
    Get more information
    Journal Article
  18. 18

    Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need by VECCHIO, Mariacristina, PALMER, Suetonia C, TONELLI, Marcello, JOHNSON, David W, STRIPPOLI, Giovanni EM

    Published in Nephrology, dialysis, transplantation (01-09-2012)
    “…People with chronic kidney disease (CKD) have a high symptom burden and experience poorer quality of life than the general population. People with CKD…”
    Get full text
    Journal Article
  19. 19

    Haemoglobin and haematocrit targets for the anaemia of chronic renal disease by Strippoli, G F, Manno, C, Schena, F P, Craig, J C

    “…Anaemia affects 60-80% of patients with renal impairment, reduces quality of life and is a risk factor for early death. Treatment options are blood…”
    Get more information
    Journal Article
  20. 20